" /> Lonafarnib - CISMeF





Preferred Label : Lonafarnib;

NCIt synonyms : 4-[2-[4-(3,10-Dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-piperidinyl]-2-oxoethyl]-1-piperidinecarboxamide;

NCIt related terms : SCH-66336; SCH 66336; 4-[2-[4-[(11R)-3,10-Dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]-1-piperidinyl]-2-oxoethyl]-1-piperidinecarboxamide;

NCIt definition : A synthetic tricyclic derivative of carboxamide with antineoplastic properties. Lonarfanib binds to and inhibits farnesyl transferase, an enzyme involved in the post-translational modification and activation of Ras proteins. Ras proteins participate in numerous signalling pathways (proliferation, cytoskeletal organization), and play an important role in oncogenesis. Mutated ras proteins have been found in a wide range of human cancers. (NCI04);

Alternative definition : NCI-GLOSS: An anticancer drug that belongs to the family of drugs called enzyme inhibitors.;

UNII : IOW153004F;

InChIKey : DHMTURDWPRKSOA-RUZDIDTESA-N;

CAS number : 193275-84-2;

Drug name : Sarasar;

Molecule name : SCH-66336; SCH 66336;

Chemical formula : C27H31Br2ClN4O2;

NSC code : 719467;

Codes from synonyms : NSC0719467; 50354; CDR0000277243; CDR0000046699;

Détails


Vous pouvez consulter :


Nous contacter.
30/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.